SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-21-000646
Filing Date
2021-11-19
Accepted
2021-11-19 16:41:06
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 skvi10q.htm   iXBRL 10-Q 602817
2 GRAPHIC image_001.jpg GRAPHIC 5943
8 ex31_1.htm EX-31.1 9079
9 ex31_2.htm EX-31.2 9000
10 ex32_1.htm EX-32.1 4132
  Complete submission text file 0001663577-21-000646.txt   3382143

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE skvi-20210930.xsd EX-101.SCH 28537
4 XBRL CALCULATION FILE skvi-20210930_cal.xml EX-101.CAL 41447
5 XBRL DEFINITION FILE skvi-20210930_def.xml EX-101.DEF 87461
6 XBRL LABEL FILE skvi-20210930_lab.xml EX-101.LAB 213701
7 XBRL PRESENTATION FILE skvi-20210930_pre.xml EX-101.PRE 179671
11 EXTRACTED XBRL INSTANCE DOCUMENT skvi10q_htm.xml XML 441818
Mailing Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120 7024337154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

IRS No.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25911 | Film No.: 211428874
SIC: 2834 Pharmaceutical Preparations